BioXcel Therapeutics, Inc. Business Finance Contracts & Agreements
29 Contracts & Agreements
- Contribution Agreements (1 contract)
- Credit Agreements (5)
- Financing Agreements (1)
- Loan Agreements (1)
- Note Agreements (1)
- Purchase Agreements (2)
- Registration Rights Agreements (1)
- Stock Agreements (2)
- Underwriting Agreements (6)
- Warrant Agreements (9)
- Form of Warrant (Filed With SEC on November 25, 2024)
- Form of Pre-funded Warrant (Filed With SEC on November 25, 2024)
- Underwriting Agreement, dated November 22, 2024, between the Company and Canaccord Genuity LLC (Filed With SEC on November 25, 2024)
- Form of Third Amended and Restated Registration Rights Agreement, among the Company and Oaktree-TCDRS Strategic Credit, LLC, Oaktree-Forrest Multi-Strategy, LLC, Oaktree-TBMR... (Filed With SEC on November 21, 2024)
- Form of New Warrant (Filed With SEC on November 21, 2024)
- Securities Purchase Agreement, dated March 25, 2024, between the Company and the Purchasers (Filed With SEC on March 25, 2024)
- Form of Accompanying Warrant (Filed With SEC on March 25, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on March 25, 2024)
- Fourth Amendment to Credit Agreement and Guaranty, dated March 20, 2024, to the Credit Agreement and Guaranty, dated April 19, 2022, by and among the Company, as the borrower,... (Filed With SEC on March 22, 2024)
- Second Amended and Restated Registration Rights Agreement, between the Company and the parties thereto, dated March 20, 2024 (Filed With SEC on March 22, 2024)
- Form of Warrant Agreement, dated March 20, 2024 (Filed With SEC on March 22, 2024)
- Third Amendment to Credit Agreement and Guaranty dated February 12, 2024, which amended the Credit Agreement and Guaranty, dated April 19, 2022, by and among the Company, as the... (Filed With SEC on February 12, 2024)
- Amended and Restated Registration Rights Agreement, dated December 5, 2023, among the Company and Oaktree-TCDRS Strategic Credit, LLC, Oaktree-Forrest Multi-Strategy, LLC,... (Filed With SEC on December 6, 2023)
- Form of New Warrant (Filed With SEC on December 6, 2023)
- Form of Amended and Restated Original Warrant (Filed With SEC on December 6, 2023)
- Waiver and First Amendment to Credit Agreement and Guaranty, by and between the Company, the lenders party thereto and Oaktree Fund Administration LLC dated November 13, 2023 (Filed With SEC on November 14, 2023)
- First Amendment to Revenue Interest Financing Agreement, dated August 4, 2022, by and between the Company, the purchasers party thereto and Oaktree Fund Administration, LLC, as... (Filed With SEC on May 9, 2023)
- Registration Rights Agreement, dated April 19, 2022, among the Company and Oaktree-TCDRS Strategic Credit, LLC, Oaktree-Forrest Multi-Strategy, LLC, Oaktree-TBMR Strategic Credit... (Filed With SEC on April 19, 2022)
- Form of Warrant (Filed With SEC on April 19, 2022)
- Underwriting Agreement, dated June 22, 2021, among the Company, the Selling Stockholder and BofA Securities, Inc., as representative of the underwriters named therein (Filed With SEC on June 25, 2021)
- Underwriting Agreement, dated July 28, 2020, among the Company, the Selling Stockholders and BofA Securities, Inc., as representative of the underwriters named therein (Filed With SEC on July 31, 2020)
- BioXcel Therapeutics, Inc. 2020 Employee Stock Purchase Plan (Filed With SEC on May 21, 2020)
- Purchase Agreement, dated February 18, 2020, among the Company and BioXcel Corporation (Filed With SEC on February 21, 2020)
- Underwriting Agreement, dated February 19, 2020, among the Company and BofA Securities, Inc., as representative of the underwriters named therein (Filed With SEC on February 21, 2020)
- Underwriting Agreement, dated September 26, 2019, between the Company and BMO Capital Markets Corp., as representative of the underwriters named therein (Filed With SEC on September 27, 2019)
- Form of Stock Purchase Agreement for September and October 2017 and January and February 2018 Private Placements (Filed With SEC on February 12, 2018)
- Amended and Restated Asset Contribution Agreement, effective November 7, 2017, by and between BioXcel Corporation and BioXcel Therapeutics, Inc (Filed With SEC on February 12, 2018)
- Grid Note, dated June 30, 2017 (Filed With SEC on February 12, 2018)
- Form of Underwriting Agreement (Filed With SEC on February 12, 2018)
